MYLAN 199 (Clonidine 0.3 mg)
Pill imprint MYLAN 199 has been identified as Clonidine hydrochloride 0.3 mg.
Clonidine is used in the treatment of opiate withdrawal; adhd; pain; benzodiazepine withdrawal; anxiety (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.3 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 199
- 0.3 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- ammonium chloride
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0301||UDL Laboratories Inc|
|49999-0438||Lake Erie Medical and Surgical Supply (repackager)|
|55887-0269||Diversified Healthcare Services Inc (repackager)|
|63874-1014||Altura Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about clonidine
- Clonidine extended-release tablets
- Clonidine patches
- Clonidine suspension
- Clonidine tablets
- Clonidine transdermal
- More (3) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.